CYP2C19-ID Kit used to support expansion | 13-May-2025 | 07:00 | RNS |
CYP2C19 ID Kit CE-IVD certification update | 02-May-2025 | 13:30 | RNS |
Additional grant funding under DEVOTE programme | 02-Apr-2025 | 07:01 | RNS |
Receipt of R&D tax credit | 02-Apr-2025 | 07:00 | RNS |
Result of RetailBook Offer | 01-Apr-2025 | 07:00 | RNS |
RetailBook Offer | 27-Mar-2025 | 15:30 | RNS |
Half-year Report | 27-Mar-2025 | 15:29 | RNS |
Equity Fundraise | 27-Mar-2025 | 15:28 | RNS |
Scottish Government testing programme investment | 17-Mar-2025 | 11:04 | RNS |
CYP2C19-ID Kit adopted for routine clinical use | 14-Mar-2025 | 07:00 | RNS |
Result of AGM | 30-Dec-2024 | 11:54 | RNS |
Genedrive® CYP2C19-ID Kit performance publi... | 27-Dec-2024 | 07:00 | RNS |
Grant of Options | 20-Dec-2024 | 12:16 | RNS |
Director/PDMR Shareholding | 20-Dec-2024 | 12:12 | RNS |
Posting of annual report and notice of AGM | 05-Dec-2024 | 15:00 | RNS |
Currency | UK Pounds |
Share Price | 1.32p |
Change Today | -0.030p |
% Change | -2.23 % |
52 Week High | 4.53 |
52 Week Low | 1.30 |
Volume | 4,165,788 |
Shares Issued | 624.90m |
Market Cap | £8.22m |
Beta | 0.00 |
RiskGrade | 747 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
17:06 | 63,628 @ 1.32p |
16:28 | 16,972 @ 1.31p |
16:19 | 497,672 @ 1.33p |
16:15 | 250,000 @ 1.33p |
16:06 | 37,372 @ 1.33p |
You are here: research